Evaluation of Percutaneous Nephrolithotomy Results and Their Potential Factors Among Local Population and Refugees
Öz
Anahtar Kelimeler
Kaynakça
- 1. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301-20.
- 2. Menon M. Urinary lithiasis: Etiology diagnosis and medical management campbell's urology. Campbell's Urology. 2005;4:3229-89.
- 3. Türk C, Neisius A, Petřík A. EAU Guidelines on Urolithiasis. Edn. presented at the EAU Annual Congress Amsterdam 2020. Publisher: EAU Guidelines Office Place published: Arnhem, The Netherlands. 2020.
- 4. Wright A, Rukin N, Smith D, De la Rosette J, Somani BK. ‘Mini, ultra, micro’–nomenclature and cost of these new minimally invasive percutaneous nephrolithotomy (PCNL) techniques. Therapeutic advances in urology. 2016;8(2):142-6.
- 5. Giusti G, Piccinelli A, Taverna G, Benetti A, Pasini L, Corinti M, et al. Miniperc? No, thank you! Eur Urol. 2007;51(3):810-4; discussion 5.
- 6. Skolarikos A, de la Rosette J. Prevention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol. 2008;18(2):229-34.
- 7. Oguz U, Resorlu B, Bayindir M, Sahin T, Bozkurt OF, Unsal A. Emergent intervention criterias for controlling sever bleeding after percutaneous nephrolithotomy. ISRN Urol. 2013;2013:760272.
- 8. Toksoz S, Dirim A, Kizilkan Y, Ozkardes H. The effect of American Society of Anesthesiology scores on percutaneous nephrolithotomy outcomes. Urol Int. 2012;89(3):301-6.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Klinik Tıp Bilimleri
Bölüm
Klinik Araştırma
Yazarlar
Yalçın Kızılkan
0000-0002-4729-0100
Türkiye
Murat Demiray
0000-0002-8176-3573
Türkiye
Abdulmecit Yavuz
0000-0001-6141-3931
Türkiye
Soner Akcin
0000-0002-8344-8892
Türkiye
Serdar Toksöz
0000-0002-2649-1157
Türkiye
Yayımlanma Tarihi
29 Ekim 2022
Gönderilme Tarihi
19 Haziran 2022
Kabul Tarihi
6 Eylül 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 4 Sayı: 3